The Pharmaceutical Innovation and the Patent System After TRIPS in China–Using Developing Countries Cases to Analyze

DOI

10.2991/aebmr.k.201128.039How to use a DOI?

Keywords

Pharmaceutical innovation, patent system, TRIPS agreement, developing country

Abstract

Due to the high technique intensity and large expenditure on R&D, patent always plays an important role in the developing of pharmaceutical industry. With the signing of TRIPS agreement, the new patent system shows a significantly effect to pharmaceutical innovation in developing country. In this paper, the author combined the economic theory and previous studies to indicate that the gradually improved patent system stimulates the incentive for pharmaceutical innovation in China. However, after analyzing the effect of TRIPS agreement to India and Brazil’s pharmaceutical innovation, I conclude that the strict patent protection caused by TRIPS agreement actually could deteriorate the result of pharmaceutical innovation in India and Brazil. Since China faces the same situation with India and Brazil, this conclusion would also be found in China. At the end of the paper, the author provided some suggestions to Chinese government based on the cases happened in India and Brazil.

Copyright

© 2020, the Authors. Published by Atlantis Press.

Open Access

This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

TY  - CONF
AU  - Jiaqi Dou
PY  - 2020
DA  - 2020/11/30
TI  - The Pharmaceutical Innovation and the Patent System After TRIPS in China–Using Developing Countries Cases to Analyze
BT  - Proceedings of the 2020 2nd International Conference on Economic Management and Cultural Industry (ICEMCI 2020)
PB  - Atlantis Press
SP  - 188
EP  - 191
SN  - 2352-5428
UR  - https://doi.org/10.2991/aebmr.k.201128.039
DO  - 10.2991/aebmr.k.201128.039
ID  - Dou2020
ER  -